Search

Emily Kearney is mum to four boys, aged four to 13, two of whom are living with an inherited sight loss condition.

• Case study - community
• Written

Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.

• News

Wednesday 2 April 2025, 7.00pm - 8.00pm - via Zoom - To celebrate National DIY Day & National Gardening Day in April we are delighted to be launching this brand new interest focused peer support group.

• Local Peer Support Group

This stunning central London half marathon, takes in some of the capital’s world-famous landmarks on closed roads.

• Running
• London

Thursday 29 May 2025, 7.00pm - 8.00pm - via Zoom - To celebrate National Creativity Day in May we are delighted to be launching this brand new interest focused peer support group.

• Local Peer Support Group

Our amazing volunteers are diverse in age, background and ethnicity. The one thing they have in common is that they are all living with, or directly affected by, an inherited sight loss condition.

• Case study - community
• Written

We talk to BBC reporter Ramadan Younes and Professor Robert Maclaren following the BBC documentary Blind Faith

• Podcast
• Audio

Join Lauren as she chats with Paula McGrath, Deputy CEO of Retina UK, about the 2025 Sight Loss Survey

• Podcast
• Audio

Would you like to help shape Retina UK’s future? Do you want to ensure decision-makers understand the impact of inherited sight loss? If so we’d love to hear from you.

• News

You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.

• News
• Retinitis pigmentosa